{"title":"Effect of Cherenkov light on cell survival in x-ray irradiation of LINAC based on Monte Carlo simulation and cell survival measurements.","authors":"Yoshiyuki Hirano, Yuka Terada","doi":"10.1088/2057-1976/ad96c1","DOIUrl":null,"url":null,"abstract":"<p><p>Cherenkov radiation is emitted during x-ray irradiation in a linear accelerator (LINAC). Cherenkov light contains many short wavelength components, including ultraviolet (UV) light, which is well-known for its bactericidal effects. A similar phenomenon is probable for human cancer cells. To assess the effect of Cherenkov light on cell death in x-ray irradiation, we employed simulations and UV cell survival data. We measured the survival rates of HeLa cells exposed to 254 nm (UVC) and 310 nm (UVB) light to determine the 50% lethal dose (LD50) required to kill 50% of the cells. For other wavelengths, we utilized literature values to establish the relationship between wavelength and LD50. Due to the broad range of the Cherenkov light spectrum, we need LD50 as a function of wavelength to estimate cell survival solely from Cherenkov light. A Monte Carlo simulation was used to calculate the fluence distribution of Cherenkov light in a 300 mm<sup>3</sup>phantom comprised of soft tissue, both with and without absorption of visible light. The latter scenario is considered to be most influenced by Cherenkov light. By combining the fluence distribution and the wavelength-LD50 relationship, we determined the distribution of the survival rate. Our findings indicate that, in the absence of absorption, a radiation dose of approximately 90 Gy or greater is necessary for Cherenkov light to have any effect. As a result, the impact of Cherenkov light on cell survival can be considered negligible for typical dose of 2 Gy.</p>","PeriodicalId":8896,"journal":{"name":"Biomedical Physics & Engineering Express","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Physics & Engineering Express","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/2057-1976/ad96c1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Cherenkov radiation is emitted during x-ray irradiation in a linear accelerator (LINAC). Cherenkov light contains many short wavelength components, including ultraviolet (UV) light, which is well-known for its bactericidal effects. A similar phenomenon is probable for human cancer cells. To assess the effect of Cherenkov light on cell death in x-ray irradiation, we employed simulations and UV cell survival data. We measured the survival rates of HeLa cells exposed to 254 nm (UVC) and 310 nm (UVB) light to determine the 50% lethal dose (LD50) required to kill 50% of the cells. For other wavelengths, we utilized literature values to establish the relationship between wavelength and LD50. Due to the broad range of the Cherenkov light spectrum, we need LD50 as a function of wavelength to estimate cell survival solely from Cherenkov light. A Monte Carlo simulation was used to calculate the fluence distribution of Cherenkov light in a 300 mm3phantom comprised of soft tissue, both with and without absorption of visible light. The latter scenario is considered to be most influenced by Cherenkov light. By combining the fluence distribution and the wavelength-LD50 relationship, we determined the distribution of the survival rate. Our findings indicate that, in the absence of absorption, a radiation dose of approximately 90 Gy or greater is necessary for Cherenkov light to have any effect. As a result, the impact of Cherenkov light on cell survival can be considered negligible for typical dose of 2 Gy.
期刊介绍:
BPEX is an inclusive, international, multidisciplinary journal devoted to publishing new research on any application of physics and/or engineering in medicine and/or biology. Characterized by a broad geographical coverage and a fast-track peer-review process, relevant topics include all aspects of biophysics, medical physics and biomedical engineering. Papers that are almost entirely clinical or biological in their focus are not suitable. The journal has an emphasis on publishing interdisciplinary work and bringing research fields together, encompassing experimental, theoretical and computational work.